Understanding exactly how cancer chemotherapy drugs inflict lethal DNA damage has long been constrained by the difficulty of modeling that damage in living systems without the confounding effects of the drugs themselves. A new set of engineered biological tools — spanning yeast, mammalian cells, and mice — now makes it possible to study topoisomerase II–induced DNA breaks with unprecedented precision and control, potentially reshaping how researchers screen next-generation anticancer and antibacterial compounds.
The study, published in PNAS, describes a suite of gain-of-function mutations in the TOP2 gene that cause the enzyme to enter a hypercleavage state — trapping its DNA-cutting complexes in position and generating the same class of protein-linked double-strand breaks produced by drugs like etoposide and fluoroquinolones. Rather than relying on exogenous compounds to induce the damage, these engineered mutants make the enzyme itself pathologically overactive. The toolkit was validated across three biological systems: Saccharomyces cerevisiae, cultured human cells, and a mouse model, providing a coherent cross-species platform for dissecting the cellular response to TOP2-mediated genotoxicity.
Topoisomerase II has been a validated drug target for decades, yet key gaps remain in understanding which DNA repair pathways are recruited, how chromatin context influences break resolution, and why certain tumor types develop resistance. This multispecies toolkit addresses those gaps by decoupling the DNA damage signal from the pharmacological noise of conventional drug treatment — a methodological advance that could accelerate mechanistic studies. The mouse model component is particularly notable, as most analogous tools have been limited to cell culture. That said, hypercleavage mutants are artificial constructs, and whether their activity fully recapitulates the spatiotemporal dynamics of drug-induced TOP2 poisoning in intact tissue remains to be demonstrated. The work is incremental in concept but genuinely enabling in practice — likely to become a widely adopted research instrument rather than a single landmark finding.